Connect Biopharma Limite... (CNTB)
NASDAQ: CNTB
· Real-Time Price · USD
1.48
0.09 (6.47%)
At close: Oct 03, 2025, 2:22 PM
6.47% (1D)
| Bid | 1.45 |
| Market Cap | 82.63M |
| Revenue (ttm) | 1.96M |
| Net Income (ttm) | -36.12M |
| EPS (ttm) | -0.81 |
| PE Ratio (ttm) | -1.83 |
| Forward PE | -0.26 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 1.49 |
| Volume | 34,011 |
| Avg. Volume (20D) | 177,887 |
| Open | 1.39 |
| Previous Close | 1.39 |
| Day's Range | 1.39 - 1.50 |
| 52-Week Range | 0.51 - 2.86 |
| Beta | -0.08 |
| Ex-Dividend Date | n/a |
About CNTB
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CNTB
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CNTB stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+16.28%
Connect Biopharma shares are trading higher after ...
Unlock content with
Pro Subscription
6 months ago
+4.04%
Connect Biopharma shares are trading higher on possible continued strength after the company reported a year-over-year increase in FY24 EPS results yesterday.
